Lanfear Dennis M 4
4 · Coherus BioSciences, Inc. · Filed Jul 24, 2024
Insider Transaction Report
Form 4
Lanfear Dennis M
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-07-22+196,500→ 196,500 totalExercise: $2.41Exp: 2034-04-11→ Common Stock (196,500 underlying)
Footnotes (1)
- [F1]On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 982,500 shares of common stock, of which 196,500 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise.